Ricin toxin B subunit enhancement of rotavirus NSP4 immunogenicity in mice

Viral Immunology

Volumn 19, Issue 1, 2006, Pages 54-63

  Choi, Nak Won ^a   Estes, Mary K ^b   Langribge, William H R ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOFETUIN; GLYCOPROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN; RICIN; RICIN A; RICIN B; ROTAVIRUS NONSTRUCTURAL PROTEIN 4; ROTAVIRUS NONSTRUCTURAL PROTEIN 4 RICIN B FUSION PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HEATING; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; NONHUMAN; PROTEIN DENATURATION; PROTEIN FUNCTION; RICINUS COMMUNIS; ROTAVIRUS; ROTAVIRUS SA 11;

ANIMALS; ANTIBODIES, VIRAL; ESCHERICHIA COLI; FEMALE; GLYCOPROTEINS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; RICIN; ROTAVIRUS; TOXINS, BIOLOGICAL; VIRAL NONSTRUCTURAL PROTEINS;

ANIMALIA; ESCHERICHIA COLI; RICINUS COMMUNIS; ROTAVIRUS; SIMIAN ROTAVIRUS A/SA11;

EID: 33645467903     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.54     Document Type: Article

References (46)

1. Falnes, P., and K. Sandvig. 2000. Penetration of protein toxins into cells. Curr. Opin. Cell. Biol. 12:407-413.
2. Endo, Y., and K. Tsurugi. 1988. The RNA N-glycosidase activity of ricin A-chain. J. Biol. Chem. 263:8735-8739.
3. Kochi, S., and R. Collier. 1993. DNA fragmentation of cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp. Cell. Res. 208:296.
4. Lambert, J.M., V.S. Goldmacher, A.R. Collision, L.M. Nadler, and W.A. Blattler. 1991. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use. Cancer Res. 51:6236-6242.
5. Sandvig, K., and S. Olsnes. 1982. Entry of the toxic proteins abrin, modeccin, ricin and diphtheria toxin into cells. J. Biol. Chem. 257:7504.
6. Tagge, E.P., J. Chandler, B. Harris, M. Czako, L. Marton, M.C. Willingham, C. Burbage, L. Afrin, and A.E. Frankel. 1996. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active. Protein Expr. Purif. 8:109-118.
7. Frankel, A.E., C. Burbage, T. Fu, E. Tagge, J. Chandler, and M. Willingham. 1996. Characterization of a ricin fusion toxin targeted to the interleukin-2 receptor. Protein Eng. 9:913-919.
8. Tonevitsky, A., A. Toptygin, I. Agapov, U. Pfueller, and A. Frankel. 1994. Renatured ricin toxin B chain made in Escherichia coli is soluble, stable, and biologically active. Biochem. Mol. Biol. Int. 32:1139-1146.
9. Piatak, M., J. Lane, E. O'Rourke, R. Clark, L. Houston, and G. Apell. 1998. ICSU Short Rep. 8:62.
10. Richardson, P., L. Roberts, J. Gould, and J. Lord. 1988. The expression of functional ricin B-chain in Saccharomyces cerevisiae. Biochim. Biophys. Acta 950: 385-395.
11. Hussain, K., C. Bowler, L. Roberts, and J. Lord. 1989. Expression of ricin B chain in Escherichia coli. FEBS Lett. 244:383-387.
12. Tonevitsky, A., A. Toptygin, I. Agapov, U. Pfueller, and A. Frankel. 1995. Renatured ricin toxin B chain made in E. coli is soluble, stable, and biologically active. Biochem. Mol. Biol. Int. 32:1139-1146.
13. Kimura, Y., S. Hase, Y. Kobayashi, T. Ikanaka, and G. Funatsu. 1988. Structures of sugar chains of ricin D. J. Biochem. 103:944-949.
14. Wales, R., P. Richardson, L. Roberts, H. Woodland, and J. Lord. 1991. Mutational analysis of the galactose binding activity of recombinant ricin B. J. Biol. Chem. 266: 19172-19179.
15. Vijayan, M., and N. Chandra. 1999. Lectins. Curr. Opin. Struct. Biol. 9:707-714.
16. Vitetta, E., and N. Yen. 1990. Expression and functional properties of genetically engineered ricin B chain lacking galactose-binding activity. Biochim. Biophys. Acta 1049:151-157.
17. Sphyris, N., J.M. Lord, R. Wales, and L. Roberts. 1995. Mutational analysis of the Ricinus communis lectin B-chains. J. Biol. Chem. 270:20292-20297.
18. Holmgren, J., I. Lonnroth, J.E. Mansson, and L. Svennerholm. 1975. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc. Nat. Acad. Sci. U.S.A. 72:2520-2524.
19. Sandvig, K., S. Olsnes, and A. Pihl. 1976. Kinetics of binding of the toxic abrin and ricin to surface receptors of human cells. J. Biol. Chem. 251:3977-3984.
20. Glass, R.I., J. Gentsch, and J.C. Smith. 1944. Rotavirus vaccines: success by reassortment? Science 265:1389-1391.
21. Petrie, B.L., M.K. Estes, and D.Y. Graham. 1983. Effects of tunicamycin on rotavirus morphogenesis and infectivity. J. Virol. 46:270-274.
22. Cunliffe, N.A., J.S. Bresee, and C.A. Hart. 2002. Rotavirus vaccines: development, current issues and future prospects. J. Infect. 45:1-9.
23. Nagahara, H., A.M. Vocero-Akbani, E.L. Snyder, A. Ho, et al. 1998. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4:1449-1452.
24. Swimmer, C., S.M. Lehar, J. McCafferty, D.J. Chiswell, W.A. Slattler, and B.C. Guild. 1992. Phage display of ricin B chain and its single binding domains: system for screening galactose-binding mutants. Proc. Natl. Acad. Sci. U.S.A. 89:3756-3760.
25. Arakawa, T., D.K.X. Chong, and W.H.R. Langridge. 1998. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat. Biotechnol. 16:292-297.
26. Medina-Bolivar, F., R. Wright, V. Funk, D. Sentz, L. Barroso, T.D. Wilkins, W. Petri, and C.L. Cramer. 2003. A non-toxic lectin for antigen delivery of plant-based mucosal vaccines. Vaccine 21:997-1005.
27. Tian, P., H. Yangfang, W.P. Schilling, D.A. Lindsay, and M.K. Estes. 1994. Rotavirus NSP4 affects intracellular calcium levels. J. Virol. 68:251-257.
28. Browne, E.P., R. Bellamy, and J.A. Taylor. 2000. Membrane-destabilizing activity of rotavirus NSP4 is mediated by a membrane-proximal amphipathic domain. J. Gen. Virol. 81:1955-1959.
29. Barton, G.M., and R. Medzhitov. 2002. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:380-383.
30. Neutra, M.R., N.J. Mantis, and J.P. Kraehenbuhl. 2001. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2:1004-1009.
31. Didierlaurent, A., J.C. Sirard, J.P. Kraehenbuhl, and M. Neutra. 2002. How the gut senses its content. Cell. Microbiol. 4:61-72.
32. Gebert, A. 1997. The role of M cells in the protection of mucosal membranes. Histochem. Cell. Biol. 108:455-470.
33. Kaiserlian, D. 1999. Antigen sampling and presentation by epithelial cells in mucosal tissues. Curr. Top. Microbiol. Immunol. 236:55-78.
34. Blumberg, H.G., W.I. Lencer, X. Zhu, H.S. Kim, S. Claypool, and S.P. Balk. 1999. Antigen presentation by intestinal epithelial cells. Immunol. Lett. 69:7-11.
35. Rosen, L., B. Podjaski, I. Bettmann, and H.F. Otto. 1981. Observations on the ultrastructure and function of the so-called "microfold" or membranous cells (M cells) by means of peroxidase as a tracer. Virchows Arch. 390:289-312.
36. Frey, A., K.T. Giannasca, R. Weltzin, P.J. Giannasca, H. Reggio, and W.I. Lencer, M.R. Neutra. 1996. Role of the glycocalyx in regulation access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 184:1045-1059.
37. Gebert, A., B. Willfuhr, and R. Pabst. 1995. The rabbit M-cell marker vimentin is present in epithelial cells of the tonsil crypt. Acta Oto-laryngol. 115:697-700.
38. Hopkins, S., F. Niedergang, I.E. Corthesy-Theulaz, and J.P. Kraehenbuhl. 2000. A recombinant Salmonella typhimurium vaccine strain is taken up and survives within murine Peyer's patch dendritic cells. Cell. Microbiol. 2:56-68.
39. Rescigno, M., M. Urbano, B. Valzasinam, M. Francolini, R. Bonasio, J.P. Kraehenbuhl, et al. Dendritic cells express occludin and claudin, open the tight junctions and sample bacteria preserving epithelial barrier integrity. Nat. Immunol. 2:361-367.
40. Huang, J.P., N. Platt, M. Wykes, J.R. Major, T.J. Powell, C.D. Jenkins, and G.G. MacPherson. 2000. A discrete sub-population of dendritic cells transport apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:435-443.
41. Kaisho, T., and S. Akira. 2002. Toll-like receptors as adjuvant receptors. Biochim. Biophys. Acta 1589:1-13.
42. Medzhitov R., and M.B. Gregory. 2002. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:380-383.
43. Hidemi, T. 2003. Antigen presentation in vaccine development. Comp. Immunol. Microbiol. Infect. Dis. 26:309-328.
44. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
45. Georgy-Chandy, A., K. Eriksson, M. Lebens, I. Nordstrom, E. Schon, and J. Holmgren. 2001. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect. Immunol. 69:5716-5725.
46. Yu, J., and W.H.R. Langridge. 2001. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 19:548-552.